Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475878 · ClinicalTrials.gov registry record · Phase 3
SSRI and Buprenorphine
A Phase 3 study, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
NCT00475878 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 147 participants.
The verdict
NCT00475878, a Phase 3 study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
Study Summary
This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider.
Interventions
- DRUG placebo
- DRUG escitalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475878
The ClinicalTrials.gov registry entry for NCT00475878 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00475878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00475878 about?
NCT00475878 is a clinical study titled "SSRI and Buprenorphine". This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider.
What is the current status of trial NCT00475878?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2006-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00475878?
The interventions under investigation include: placebo (DRUG), escitalopram (DRUG).
Who is sponsoring clinical trial NCT00475878?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.